Topics

Articles

Ways to reimagine pharma’s operating model and KPIs for commercial success in an AI-driven future.

Measuring What Matters

Brett Casper explores the marketplace complexities that manufacturers face regularly. 

Asembia 2025: Navigating the Product Commercialization Process

Videos

Blake Powers, CEO, Medigi, discusses how face-to-face collaboration and streamlined commercialization strategies are helping life sciences companies deliver therapies more efficiently to patients.

Asembia 2025: The Role of Face-to-Face Connection in Pharma Commercialization

Joydeep Ganguly, SVP, corporate operations, interim CIO, Gilead Sciences, shares insights on how sustainability has evolved from a compliance requirement to a key business strategy, driving operational efficiencies, innovation, and long-term growth.

LogiPharma Europe 2025: Driving Business Success Through Sustainability

The new firm—with 13 manufacturing facilities spanning France, Sweden, and Spain—will support the pharma supply chain through to commercialization. 

Meribel Pharma Solutions Joins the CDMO Marketplace

Will Robinson, program director, LogiPharma, reveals why the conference will be moved to Vienna moving forward. 

LogiPharma 2025: LogiPharma to Move to Vienna for Sustainability and Focused Sessions

The partnership focuses on enhancing the patient experience by providing greater affordability and access to specialty meds.

PharmaCord, Mercalis Merge in an Effort to Support the Patient Journey

The injection for the treatment of psoriatic arthritis—among other indications—is a biosimilar to Stelara. 

Selardsi Launches in the US Market

In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, explains the challenges associated with meeting the FDA’s 2025 CGT forecasted approval goal. 

Tackling Gaps in Manufacturing, Funding, and Expertise

The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.

Commercial Channels